Congrats to @sunilacharya13, @lab_rezvani & collaborators for publishing in Cancer Discovery how CD28 costimulation enhances CAR-NK cell function! CAR27 NK cells with CD28-based costimulation were ~3x more likely to exhibit serial killing. Learn more: https://t.co/Gf1J3F5P5S

104 Nobel Prizes have been won by NIH researchers But yeah shut it down

In Brief This Week: Bruker, Qiagen, Prenetics, CellChorus, T2 Biosystems, More

Attending #SITC24 this week?Be sure to check out the 𝒇𝒐𝒖𝒓 presentations featuring data from @CellChorus' single-cell analysis technology!

Attending SITC 2024? Four abstracts from CellChorus and collaborators feature TIMING data! Join us to learn how dynamic single-cell analysis improves screening donors, enhancing ADCC, quantifying potency/viability, and more. https://t.co/u5Ay8e37u2 @sitcancer

Want to learn how to apply TIMING™ for potency and viability analysis in process development? Meet with us at BioProcess International in Boston Sept 25th + 26th. Already registered? Book a meeting in the conference app: https://t.co/3qEXcQXGNi @BioProcessIntl @InformaConnect

🚨 @IndeeLabs posted a manuscript that applies TIMING™ data from @CellChorus to show that CAR-T cells manufactured with the Indee platform have superior motility and resistance to activation-induced cell death (AICD). https://t.co/KX25PzCaFe @RBerdeaux @MohsenFathi1993

💥Publication alert: CAR T cells from individuals with complete response were enriched for migration and serial killing. Learn more about the TIMING™ data: https://t.co/OOFveS2V9z @NatureCancer @UH_NVLab @MohsenFathi1993 #singleCellAnalysis #CART #cellTherapy

YC S21's @CellChorus has received $2.5 million in support from @ncats_nih_gov @NIH to extend its TIMING™ single-cell analysis platform that quantifies which immune cells perform best and why. https://t.co/HKw6Swi1qU

Wow, I only see a few dozen tickets available for @NWSL newcomer @wearebayfc's home opener against the @HoustonDash ⚽ @brandichastain @LeslieOsborne12 @daniellevslaton @SJEarthquakes @SixthStreetNews @PayPalPark @USWNT

Researchers from the @UH_NVLab at @UHouston have applied TIMING™ data to study redundancies in cytotoxic mechanisms employed by CAR T cells. See an example nanowell video below and the paper in Cell Death & Disease: https://t.co/E8KMaAQftM #singleCell #leukemia #immunooncology

Join @CellChorus at #SLAS2024 in Boston! @RBerdeaux will present on Monday Feb 5 at 10:30 in the Precision Medicine in Immunotherapy session. @SLAS_Org #singleCell #immunotherapy #ImmunoOncology #CarT #CarNK #antibodies

Andrew J. Last, PhD, (ECP & COO of @BioRad) has joined the CellChorus board of directors! Learn more: https://t.co/FI9kB6VuMf

Looking forward to #TCDisrupt2023! Thank you to the @TechCrunch team for recognizing the power of the @CellChorus TIMING™ platform to advance immune-cell based therapies.

.@CellChorus is a perfect example of how #tech giants are embracing the marriage between #computation and #biology. It's exciting to see! Congrats, team, on getting into the program!

Thank you to the @NVIDIA Inception team for their support! @CellChorus applies AI to evaluate how immune cells move, interact and perform over time https://t.co/OyHhDBczI4 #ai #artificialIntelligence #ml #machineLearning #cellTherapy #immunotherapy #immunooncology #singleCell

CellChorus Wins Phase I National Science Foundation SBIR Grant. The award will support development of microscale arrays for single-cell analysis in the life sciences industry.

"Amid international VC decline, here's what Houston startups received investment, grant funding last quarter" @nataliejharms and @AliceEats via @InnoMapHou https://t.co/NUdiI2EBD9 #singleCell #ai #ml #immunotherapy #cellTherapy #immunoOncology

The @NIH has awarded @CellChorus (YC S21) $2.3M to scale its visual AI technology that predicts cell response to life-saving immunotherapies, enabling scientists to create new medications faster, at lower cost, and with a higher success rate. https://t.co/lizZ70itZN

Looking forward to seeing everyone at @NYUStern for @EFrontierLabs 2023 later this week!!